{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:17:44Z","timestamp":1791231464189,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":3355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.exphem.2012.12.004","type":"journal-article","created":{"date-parts":[[2012,12,30]],"date-time":"2012-12-30T23:33:27Z","timestamp":1356910407000},"page":"335-345.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell\u2013derived hematopoiesis model"],"prefix":"10.1016","volume":"41","author":[{"given":"Michael","family":"Melkus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise","family":"Bennaceur-Griscelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Valogne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Flamant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Chomel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Sorel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Deininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Teresa","family":"Mitjavila-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali G.","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2012.12.004_bib1","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.exphem.2012.12.004_bib2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2012.12.004_bib3","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.1038\/sj.onc.1206087","article-title":"BCR\/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability","volume":"21","author":"Skorski","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2012.12.004_bib4","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1056\/NEJMe068073","article-title":"Circumventing resistance to kinase-inhibitor therapy","volume":"354","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2012.12.004_bib5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.exphem.2012.12.004_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1099480","article-title":"Overriding imatinib resistance with a novel ABL kinase inhibitor","volume":"305","author":"Shah","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.exphem.2012.12.004_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","article-title":"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl","volume":"7","author":"Weisberg","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2012.12.004_bib8","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.12.004_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in\u00a0vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.12.004_bib10","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2404609","article-title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies","volume":"21","author":"Jiang","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2012.12.004_bib11","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1634\/stemcells.2004-0033","article-title":"Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in\u00a0vivo","volume":"22","author":"Schuringa","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2012.12.004_bib12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2012.12.004_bib13","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrd2324","article-title":"Flying under the radar: the new wave of BCR-ABL inhibitors","volume":"6","author":"Quintas-Cardama","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.exphem.2012.12.004_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2009.09.028","article-title":"AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance","volume":"16","author":"O\u2019Hare","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2012.12.004_bib15","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3109\/10428194.2010.520774","article-title":"Extensive analysis of the T315I substitution and detection of additional ABL mutations in progenitors and primitive stem cell compartment in a patient with tyrosine kinase inhibitor-resistant chronic myeloid leukemia","volume":"51","author":"Chomel","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2012.12.004_bib16","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1038\/sj.onc.1206607","article-title":"Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells","volume":"22","author":"Coppo","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2012.12.004_bib17","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1073\/pnas.97.4.1737","article-title":"Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate","volume":"97","author":"Era","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2012.12.004_bib18","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1242\/dev.128.22.4597","article-title":"Clonal analysis of differentiating embryonic stem cells reveals a hematopoietic progenitor with primitive erythroid and adult lymphoid-myeloid potential","volume":"128","author":"Perlingeiro","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.exphem.2012.12.004_bib19","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1242\/dev.129.8.2003","article-title":"Expression of CD41 on hematopoietic progenitors derived from embryonic hematopoietic cells","volume":"129","author":"Mitjavila-Garcia","year":"2002","journal-title":"Development"},{"key":"10.1016\/j.exphem.2012.12.004_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1242\/dev.111.2.259","article-title":"Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture","volume":"111","author":"Wiles","year":"1991","journal-title":"Development"},{"key":"10.1016\/j.exphem.2012.12.004_bib21","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1373\/clinchem.2004.047274","article-title":"Double-gradient-denaturing-gradient gel electrophoresis for mutation screening of the BCR-ABL tyrosine kinase domain in chronic myeloid leukemia patients","volume":"51","author":"Sorel","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.exphem.2012.12.004_bib22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2010-12-322081","article-title":"Musashi 2 is a regulator of the hematopoietic stem cell compartment identified by a retroviral insertion screen and knockout mice","volume":"118","author":"de Andres-Aguayo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.12.004_bib23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nm.2187","article-title":"Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia","volume":"16","author":"Kharas","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2012.12.004_bib24","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.exphem.2012.12.004_bib25","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","article-title":"Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow","volume":"92","author":"Pear","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.12.004_bib26","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1038\/sj.onc.1206091","article-title":"Studying the pathogenesis of BCR-ABL+ leukemia in mice","volume":"21","author":"Van Etten","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2012.12.004_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/71691","article-title":"Reversibility of acute B-cell leukaemia induced by BCR-ABL1","volume":"24","author":"Huettner","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2012.12.004_bib28","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1182\/blood-2003-03-0768","article-title":"Inducible expression of BCR\/ABL using human CD34 regulatory elements results in a megakaryocytic myeloproliferative syndrome","volume":"102","author":"Huettner","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.12.004_bib29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood-2003-12-4369","article-title":"Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis","volume":"105","author":"Koschmieder","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.12.004_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/emboj.2008.253","article-title":"Cancer induction by restriction of oncogene expression to the stem cell compartment","volume":"28","author":"Perez-Caro","year":"2009","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2012.12.004_bib31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/386488a0","article-title":"A common precursor for primitive erythropoiesis and definitive haematopoiesis","volume":"386","author":"Kennedy","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2012.12.004_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(02)00680-3","article-title":"HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors","volume":"109","author":"Kyba","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2012.12.004_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ccr.2011.03.003","article-title":"Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036","volume":"19","author":"Chan","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2012.12.004_bib34","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1158\/0008-5472.CAN-10-3224","article-title":"The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile","volume":"71","author":"Eide","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2012.12.004_bib35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature08675","article-title":"Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors","volume":"463","author":"Zhang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2012.12.004_bib36","doi-asserted-by":"crossref","first-page":"19466","DOI":"10.1073\/pnas.0609239103","article-title":"Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants","volume":"103","author":"Skaggs","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2012.12.004_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2010.06.007","article-title":"An RNAi screen identifies Msi2 and Prox1 as having opposite roles in the regulation of hematopoietic stem cell activity","volume":"7","author":"Hope","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2012.12.004_bib38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ng.392","article-title":"Lin28 promotes transformation and is associated with advanced human malignancies","volume":"41","author":"Viswanathan","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2012.12.004_bib39","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1182\/blood-2009-04-219410","article-title":"Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation","volume":"114","author":"Nicolini","year":"2009","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1200598X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1200598X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:30:14Z","timestamp":1759566614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X1200598X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0301472X1200598X"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2012.12.004","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell\u2013derived hematopoiesis model","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2012.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}